Patents by Inventor David Peter Siderovski

David Peter Siderovski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using lung or bronchial epithelial cells to identify bitter taste modulators
    Patent number: 9128079
    Abstract: Provided herein are cell lines and assays that can be utilized to identify taste receptor modulators.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: September 8, 2015
    Assignees: The Coca-Cola Company, The University of North Carolina
    Inventors: Harish Radhakrishna, Michael D. Brown, David Peter Siderovski, Adam Kimple, Staci Padove Cohen
  • CELL LINES COMPRISING ENDOGENOUS TASTE RECEPTORS AND THEIR USES
    Publication number: 20130040316
    Abstract: Provided herein are cell lines and assays that can be utilized to identify taste receptor modulators.
    Type: Application
    Filed: August 8, 2012
    Publication date: February 14, 2013
    Applicants: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, THE COCA-COLA COMPANY
    Inventors: Harish Radhakrishna, Michael D. Brown, David Peter Siderovski, Adam Kimple, Staci Padove Cohen
  • CELL LINES COMPRISING ENDOGENOUS TASTE RECEPTORS AND THEIR USES
    Publication number: 20130040317
    Abstract: Provided herein are cell lines and assays that can be utilized to identify taste receptor modulators.
    Type: Application
    Filed: August 8, 2012
    Publication date: February 14, 2013
    Applicants: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, THE COCA-COLA COMPANY
    Inventors: Harish Radhakrishna, Michael D. Brown, David Peter Siderovski, Adam Kimple, Staci Padove Cohen
  • Apoptosis-inducing factor
    Patent number: 7371834
    Abstract: The present invention related generally novel mammalian apoptosis-inducing factors, polynucleotides encoding such factors and methods related thereto.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: May 13, 2008
    Assignees: Amgen Inc., Centre National de la Recherche Scientifique
    Inventors: Josef M. Penninger, Guido P. Kroemer, David Peter Siderovski, Naoufal Zamzami, Santos A. Susin, Bryan E. L. Snow
  • Apoptosis-inducing factor
    Patent number: 6773911
    Abstract: The present invention related generally novel mammalian apoptosis-inducing factors, polynucleotides encoding such factors and methods related thereto.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: August 10, 2004
    Assignees: Amgen Canada Inc., Centre National de la Recherche Scientifique
    Inventors: Josef M. Penninger, Guido P. Kroemer, David Peter Siderovski, Naoufal Zamzami, Santos A. Susin, Bryan E. L. Snow
  • Apoptosis-inducing factor
    Publication number: 20030211514
    Abstract: The present invention related generally novel mammalian apoptosis-inducing factors, polynucleotides encoding such factors and methods related thereto.
    Type: Application
    Filed: December 2, 2002
    Publication date: November 13, 2003
    Inventors: Josef M. Penninger, Guido P. Kroemer, David Peter Siderovski, Naoufal Zamzami, Santos A. Susin, Bryan E.L. Snow
  • Methods of inhibiting syp binding to a CTLA-4 receptor
    Patent number: 5786152
    Abstract: Disclosed are methods for identifying a molecule that inhibits SYP activity in a T-cell.
    Type: Grant
    Filed: April 26, 1996
    Date of Patent: July 28, 1998
    Assignee: Amgen Inc.
    Inventors: Luc Edgar Joseph Marengere, David Peter Siderovski, Tak Wah Mak